SynthesisJournal of global health2024
All-cause and cardiovascular mortality in dual sensory impairment patients: A meta-analysis of cohort studies.
Synthesis in Journal of global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of sensory impairments on the risk of mortality and hospitalisations: longitudinal insights from REGLINK-SHAREDK.BMJ public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This meta-analysis is to determine the risk of all-cause mortality and cardiovascular mortality of dual sensory impairment (DSI). Methods: Relevant cohort studies were searched in Medline with PubMed, Cochrane Library, and EMBASE databases. The quality of the included studies was assessed based on the Newcastle-Ottawa Quality Assessment Scale (NOS). STATA software (USA) was used to conduct statistical analyses. To determine the source of heterogeneity, subgroup and sensitivity analyses were carried out. Funnel plots and the Egger's test were used for detecting publication bias. Results: This meta-analysis incorporated 12 cohort studies (1992-2024), containing 310 211 patients. Pooled analysis showed that DSI patients had a higher risk of all-cause mortality (hazard ratio (HR) = 1.442; 95% confidence interval (CI) = 1.303-1.596, I Conclusions: This study shows that DSI is linked to higher risks of all-cause and cardiovascular mortality, suggesting that DSI should be regarded as an independent mortality risk factor. Physicians treating individuals with DSI should assess its impact on life expectancy. Registration: The protocol was previously registered on the International Prospective Register of Systematic Reviews (PROSPERO) platform (CRD42024527256).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.